Product Data Sheet

LIMK1 inhibitor 1

Catalog No. A54790

main product photo
LIMK1 Inhibitor 1 is a selective inhibitor of LIM domain kinase 1 (LIMK1), a critical regulator of actin cytoskeletal dynamics. This compound demonstrates potential anti-cancer activity by disrupting cancer cell migration and invasion. LIMK1 Inhibitor 1 is applicable in research focused on understanding the role of LIMK1 in oncogenesis and exploring therapeutic strategies for cancer treatment.
Chemical Information
Catalog NumA54790
M. Wt265.40
FormulaC12H15N3S2
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.332904-10-6
Synonyms
SMILESNC1=C2C(SC3=C2CCCCC3)=NC(SC)=N1
Biological Activity
DescriptionLIMK1 Inhibitor 1 is a selective inhibitor of LIM domain kinase 1 (LIMK1), a critical regulator of actin cytoskeletal dynamics. This compound demonstrates potential anti-cancer activity by disrupting cancer cell migration and invasion. LIMK1 Inhibitor 1 is applicable in research focused on understanding the role of LIMK1 in oncogenesis and exploring therapeutic strategies for cancer treatment.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.